Efficacy and safety of a weekly infusion of recombinant human C1 inhibitor (rhC1INH) for the prophylaxis of hereditary angioedema attacksA. Reshef,D. Moldovan,K. Obtulowicz, S. Visscher,A. RelanALLERGY（2012）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
